Go Pro

Allstate FY2026 EPS Forecast Increased by DOWLING & PARTN

Allstate logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • DOWLING & PARTN raised Allstate’s FY2026 EPS forecast to $35.50 from $30.50, well above the $31.93 consensus estimate, while projecting FY2027 EPS of $25.50.
  • Allstate reported quarterly EPS of $8.99, beating estimates of $6.06 by $2.93; revenue rose 11.8% year over year to $15.43 billion.
  • Analyst sentiment remains mixed: the stock has an average “Hold” rating and a $265.53 price target, while recent price-target increases contrast with a Citi “Sell” downgrade citing potentially unsustainable operating returns.
  • MarketBeat previews top five stocks to own in September.

The Allstate Corporation (NYSE:ALL - Free Report) - Stock analysts at DOWLING & PARTN raised their FY2026 earnings per share (EPS) estimates for Allstate in a research note issued to investors on Friday, August 7th. DOWLING & PARTN analyst D. Lukpanov now anticipates that the insurance provider will post earnings of $35.50 per share for the year, up from their prior estimate of $30.50. The consensus estimate for Allstate's current full-year earnings is $31.93 per share. DOWLING & PARTN also issued estimates for Allstate's FY2027 earnings at $25.50 EPS.

A number of other research firms also recently commented on ALL. Keefe, Bruyette & Woods increased their target price on Allstate from $242.00 to $255.00 and gave the company a "market perform" rating in a research report on Wednesday, July 8th. Morgan Stanley set a $265.00 price target on shares of Allstate in a research note on Tuesday. Wells Fargo & Company lowered shares of Allstate from an "equal weight" rating to an "underweight" rating and increased their price objective for the company from $243.00 to $250.00 in a research report on Friday. Wall Street Zen upgraded shares of Allstate from a "hold" rating to a "buy" rating in a report on Monday, July 20th. Finally, Mizuho upped their target price on shares of Allstate from $255.00 to $272.00 and gave the company an "outperform" rating in a research report on Thursday, July 9th. Three analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $265.53.

Read Our Latest Research Report on Allstate

Allstate Stock Performance

NYSE:ALL opened at $261.94 on Wednesday. The company has a market cap of $66.23 billion, a price-to-earnings ratio of 5.23, a PEG ratio of 0.44 and a beta of 0.16. Allstate has a 1 year low of $188.08 and a 1 year high of $277.22. The stock's 50 day simple moving average is $243.78 and its two-hundred day simple moving average is $221.66. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, beating analysts' consensus estimates of $6.06 by $2.93. The company had revenue of $15.43 billion during the quarter, compared to analyst estimates of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%.The firm's revenue was up 11.8% on a year-over-year basis. During the same period in the prior year, the company earned $5.94 earnings per share.

Allstate Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Monday, August 31st will be paid a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Monday, August 31st. Allstate's payout ratio is presently 8.63%.

Insiders Place Their Bets

In other news, insider Mark Q. Prindiville sold 1,550 shares of the firm's stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $216.27, for a total value of $335,218.50. Following the completion of the sale, the insider owned 27,558 shares in the company, valued at approximately $5,959,968.66. This trade represents a 5.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Andrea Redmond sold 2,225 shares of Allstate stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $202.91, for a total transaction of $451,474.75. Following the transaction, the director directly owned 2,225 shares of the company's stock, valued at approximately $451,474.75. This represents a 50.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 36,771 shares of company stock valued at $9,673,506 over the last three months. 1.55% of the stock is owned by company insiders.

Institutional Trading of Allstate

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. MV Capital Management Inc. bought a new position in shares of Allstate during the fourth quarter valued at approximately $25,000. Gables Capital Management Inc. purchased a new stake in shares of Allstate in the second quarter worth approximately $26,000. Navalign LLC bought a new stake in shares of Allstate during the 4th quarter worth approximately $27,000. Kelleher Financial Advisors bought a new stake in shares of Allstate during the 2nd quarter worth approximately $28,000. Finally, Evolution Wealth Management Inc. boosted its holdings in Allstate by 7,000.0% during the 1st quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider's stock valued at $29,000 after acquiring an additional 140 shares during the period. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate News Roundup

Here are the key news stories impacting Allstate this week:

  • Positive Sentiment: JPMorgan raised its price target for Allstate from $282 to $292 and maintained an “overweight” rating, implying meaningful upside based on its current valuation. Benzinga report
  • Positive Sentiment: Piper Sandler also increased its price target, lifting it from $268 to $300 and reiterating an “overweight” rating. The revision suggests the firm expects continued earnings strength or improved valuation support. Ticker Report article
  • Neutral Sentiment: Allstate is preparing its Allie platform as part of an agentic artificial-intelligence strategy. The initiative could improve productivity and customer service over time, although its financial impact remains uncertain. Allstate preps Allie platform to drive agentic AI strategy
  • Negative Sentiment: Citi downgraded Allstate to “sell”, arguing that the insurer’s recent operating returns appear “unsustainable.” The call challenges the durability of the company’s recent profit performance. Allstate cut to sell at Citi
  • Negative Sentiment: Insider John E. Dugenske sold 32,996 shares worth approximately $8.9 million, reducing his position by about 72%. While insider sales can be planned for personal reasons, the size of the transaction may weigh on sentiment. SEC insider transaction filing
  • Negative Sentiment: DOWLING & PARTN projected FY2028 EPS of $25.50, below the current consensus estimate of $31.40 for the full year. The lower forecast raises concerns about longer-term earnings growth.

About Allstate

(Get Free Report)

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.

Read More

Earnings History and Estimates for Allstate (NYSE:ALL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Allstate Right Now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines